OXT-OXTR pathway active in posterior retina

Article

The posterior retina is a site of oxytocin (OXT) activation of the oxytocin receptor (OXTR), according to a study published online.

The posterior retina is a site of oxytocin (OXT) activation of the oxytocin receptor (OXTR), which may serve as a paracrine signalling pathway contributing to communication between the retinal pigment epithelium and the cone photoreceptor, according to a study published online in Investigative Ophthalmology and Visual Science.

Researchers from the University of Wisconsin (USA), used immunohistochemistry using cell specific markers to localize OXT within a rhesus retina, and reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry to assess the expression of OXTR in both rhesus and human retinas.

To determine the expression of OXTR in cultured human foetal retinal pigment epithelium (hfRPE) cells, the researchers used single-cell RT-PCR and Western blot analyses. To assess transient mobilization of intracellular Ca2+ ([Ca2+]i), the hfRPE cells were loaded with Fura-2-acetoxymethyl ester and studied by ratiometric Ca2+ imaging.

They found that, in the rhesus retina, OXT was expressed in the cone photoreceptor extracellular matrix, and OXTR mRNA and protein were expressed in both the human and rhesus retinal pigment epithelium. In the cultured hfRPE cells, OXTR mRNA and protein expression were observed, and a transient increase of [Ca2+]i was induced by exposure of these cells to 100 nM OXT.

The researchers concluded that OXT and OXTR are present in the posterior retina and OXT causes an increase in hfRPE [Ca2+]i , suggesting that the retina is an active site of the OXT-OXTR signaling pathway.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.